Clinical Trial Update: Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing eltrombopag for improving thrombocytopenia in MYH9-related disease; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myh9-related Disease
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Blood Platelet Disorders | Phase 2 | Status: COMPLETED | Results posted: 2011-07-21